Shima Hadidchi, MD , will work closely with you to set realistic expectations, discuss potential benefits and side effects, and develop a comprehensive plan tailored to your individual needs
GLP-1-RA such as liraglutide [4], semaglutide [5], and the dual agonist tirzepatide [6], activating both the GLP1- and the gastric-inhibitory polypeptide receptor (GIP-R), have been shown to significantly reduce body weight, making them a promising therapeutic option for the treatment of obesity
The introduction of semaglutide has been a major advancement in the field of weight management
Counsel women of childbearing potential regarding the potential risk to the fetus from topiramate exposure, and consider alternative therapeutic options in women who are planning a pregnancy
2023 Jul 2;12(7):1375
Eat smaller, more frequent meals : This approach aligns with the medication's mechanism and may reduce reflux that contributes to bad taste